Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

H Christoph Westphal


  • Large Shareholder, Director at Flex Pharma Inc. (FLKS), 2017-07-27
  • Executive Chairman at Verastem Inc. (VSTM), 2015-07-01
  • Large Shareholder, Director at Ovascience Inc. (OVAS), 2014-03-11
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
FLKS $7.31 7,000 Large Shareholder, Officer, Director 3,941,118 2016-11-08 Filing
FLKS $5.70 8,870 Large Shareholder, Officer, Director 3,934,118 2016-11-07 Filing
FLKS $11.28 2,700 Large Shareholder, Officer, Director 3,212,861 2016-06-23 Filing
FLKS $11.03 2,900 Large Shareholder, Officer, Director 3,210,161 2016-06-22 Filing
FLKS $11.07 2,800 Large Shareholder, Officer, Director 3,207,261 2016-06-21 Filing